Abstract Background COVID-19 continuously causes severe disease conditions and significant mortality. We evaluate whether easily accessible biomarkers can improve risk prediction of severe disease outcomes. Methods Our study analysed 426 COVID-19 patients collected by German CAPNETZ and PROGRESS study…